Jiro Tsujita
Fukuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Ureteral Orifice Stricture After Transurethral Resection of Bladder Tumors Involving the Ureteral Orifice or Adjacent Area: Clinical Course and Outcomes.
Journal: In vivo (Athens, Greece)
Published: April 08, 2026
Early Progressive Disease During Nivolumab Plus Ipilimumab Therapy Predicts Poor Survival in Japanese Patients with Advanced Renal Cell Carcinoma: A Single-Center 12-Week Landmark Study.
Journal: Research and reports in urology
Published: March 27, 2026
Early Progressive Disease Predicts Poor Outcomes of Second-line VEGFR Tyrosine Kinase Inhibitor Therapy After First-line Nivolumab Plus Ipilimumab in Advanced Renal Cell Carcinoma.
Journal: Anticancer research
Published: March 04, 2026
Older Age and Outcomes of Intravesical Bacillus Calmette-Guérin for Non-muscle-invasive Bladder Cancer.
Journal: In vivo (Athens, Greece)
Published: February 07, 2026
Real-world Delivery and Outcomes of Intravesical BCG for Non-muscle-invasive Bladder Cancer.
Journal: Anticancer research
Published: February 05, 2026
Real-world Treatment Selection and Shared Decision-making in De Novo Metastatic Castration-sensitive Prostate Cancer in Japan.
Journal: Cancer diagnosis & prognosis
Published: November 26, 2025
Perioperative Chemotherapy in Bladder and Upper Tract Urothelial Carcinoma: Outcomes by Nodal Status and Lymphovascular Invasion.
Journal: Cancers
Published: November 12, 2025
Clinical Outcomes of Avelumab Maintenance Following Full-Dose, Reduced-Dose Cisplatin, or Carboplatin-Based Chemotherapy in Advanced Urothelial Carcinoma.
Journal: Research and reports in urology
Published: July 15, 2025
Showing 1-9 of 9
Last Updated: 09/26/2026